溶解循环
微生物学
细菌
生物
病毒学
肠杆菌科
肠道病毒
免疫系统
噬菌体
噬菌体疗法
肠道细菌
基因
基因工程
医学
免疫学
抗生素
细菌遗传学
作者
Rogério Aparecido Bataglioli,Hiba Baaziz,Hallie Avalos,Lindsay Smith,Zachary Baker,Rita Makhlouf,David da Silva Barreira,Harsimran Kaur,Teresa Southard,Bryan Boen Hsu
标识
DOI:10.1038/s41564-026-02484-3
摘要
Phage therapy is a promising antibacterial approach but it has limited efficacy against enteric bacterial infections, such as Salmonella enterica Typhimurium (STm). Here we hypothesized that establishing high concentrations of a pathogen-targeting phage in the gut before infection would prophylactically protect against future infection. To this end, we engineered non-pathogenic Escherichia coli to encode a prophage that produces obligately lytic phage progeny targeting STm while overcoming its host defence systems, including restriction-modification systems. We show that prophylactic gut colonization with this lytic phage-producing lysogen of E. coli produces high levels of lytic phage before infection, inhibits the establishment of STm after infection and improves survival in mouse models of STm-induced colitis. Using a mutant STm strain limited to intestinal colonization, we show that phage-producing E. coli consistently colonized, produced high phage levels and eliminated STm from the intestinal tract. Our findings present a proof-of-concept that prophylactic prophage therapy can protect against an enteric infection.
科研通智能强力驱动
Strongly Powered by AbleSci AI